Article info
PDFEconomics
Low-molecular-weight heparin was more cost-effective than intravenous heparin for treating proximal venous thrombosis
Citation
Low-molecular-weight heparin was more cost-effective than intravenous heparin for treating proximal venous thrombosis
Online issue publication
March 03, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions